Zentek (CVE:ZEN) Trading Down 31.6% – Here’s Why

Zentek Ltd. (CVE:ZENGet Free Report)’s share price traded down 31.6% on Friday . The company traded as low as C$0.86 and last traded at C$0.93. 1,053,227 shares traded hands during trading, an increase of 1,143% from the average session volume of 84,742 shares. The stock had previously closed at C$1.36.

Zentek Stock Down 31.6%

The stock’s 50-day moving average price is C$0.80 and its two-hundred day moving average price is C$0.94. The stock has a market capitalization of C$100.02 million, a P/E ratio of -11.63 and a beta of 0.34. The company has a current ratio of 1.00, a quick ratio of 7.59 and a debt-to-equity ratio of 15.41.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.

Read More

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.